If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||||
![]() British Journal of DermatologyVolume 151 Issue 3, Pages 587 - 593 Published Online: 14 Sep 2004 Journal compilation © 2010 British Association of Dermatologists An Official Journal of the British Association of Dermatologists
Abstract | References | Full Text: HTML, PDF (Size: 134K) | Related Articles | Citation Tracking
Clinical and Laboratory Investigations
Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984–88 and 1994–98) Copyright 2004 British Association of Dermatologists KEYWORDS melanoma • Northern Ireland • survival Summary
Background The incidence of cutaneous malignant melanoma has been rising steadily in Caucasian populations for several decades, with a doubling time of 10–14 years. An increase in incidence of about 5% per year has been reported in most Caucasian populations since the early 1960s. Objectives This study was designed to determine the changing incidence of primary cutaneous malignant melanoma in Northern Ireland and to examine changes in survival rates from cutaneous malignant melanoma in two 5-year periods, 1984–88 and 1994–98. Methods One thousand three hundred and twenty-six patients with invasive primary cutaneous melanoma were included in the study. Results The age standardized rate of melanoma rose from 4·3 per 100 000 population per year in men and 8·6 per 100 000 population per year in women to 7·7 and 11·8, respectively, per 100 000 population per year in the 1994–98 period. Overall, the absolute 5-year survival for the 1984–88 period was 71·0% [95% confidence interval (CI) 66·9–75·1%] and 77·4% (95% CI 73·4–81·4%) for the 1994–98 period. Women consistently showed better survival at all ages and within almost all categories of thickness of primary tumour. Younger patients of both sexes showed better survival rates. Conclusions When survival rates between the 1984–88 and 1994–98 periods were compared using multivariate analysis, we found that patients diagnosed in the second period had a one-third lower risk of dying than those in the earlier period. Much of this reduction was explained by changes in the number of melanomas of thin Breslow depth and ulcerated melanomas. Accepted for publication 5 February 2004 |